|
JPS59196876A
(ja)
|
1983-04-22 |
1984-11-08 |
Sumitomo Chem Co Ltd |
１，２，４−オキサジアゾ−ル誘導体、その製造法およびそれを有効成分とする除草剤
|
|
WO1986003203A1
(fr)
|
1984-11-22 |
1986-06-05 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Derives de thienylthiazole
|
|
CA2044533A1
(en)
*
|
1990-06-29 |
1991-12-30 |
Philippe Guerry |
Substituted aminoalkylbiphenyl derivatives
|
|
WO1995032963A1
(en)
|
1994-06-01 |
1995-12-07 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Thienylazole compound and thienotriazolodiazepine compound
|
|
WO1996004278A1
(en)
|
1994-08-02 |
1996-02-15 |
Nippon Soda Co., Ltd. |
Oxazole derivative, process for producing the same, and herbicide
|
|
WO1996006096A1
(en)
|
1994-08-23 |
1996-02-29 |
Nissan Chemical Industries, Ltd. |
Pyridine derivative
|
|
DE19536809A1
(de)
|
1995-10-02 |
1997-04-03 |
Basf Ag |
Heterocyclisch substituierte Salicylsäurederivate
|
|
CA2190699A1
(en)
*
|
1995-12-08 |
1997-06-09 |
Johannes Aebi |
Tertiary amines
|
|
EP0873328A1
(en)
*
|
1996-01-05 |
1998-10-28 |
Novartis AG |
Substituted 1,2,4,6-thiatriazines useful as herbicides
|
|
WO1998008845A1
(en)
|
1996-08-27 |
1998-03-05 |
Novartis Ag |
Herbicidal s-substituted 1,2,4,6-thiatriazines
|
|
JPH11171848A
(ja)
*
|
1997-09-26 |
1999-06-29 |
Fujirebio Inc |
芳香族アミド誘導体
|
|
UA71971C2
(en)
|
1999-06-04 |
2005-01-17 |
Agoron Pharmaceuticals Inc |
Diaminothiazoles, composition based thereon, a method for modulation of protein kinases activity, a method for the treatment of diseases mediated by protein kinases
|
|
AU2001249670A1
(en)
*
|
2000-04-03 |
2001-10-15 |
3-Dimensional Pharmaceuticals, Inc. |
Substituted thiazoles and the use thereof as inhibitors of plasminogen activatorinhibitor-1
|
|
US20030171399A1
(en)
|
2000-06-28 |
2003-09-11 |
Tularik Inc. |
Quinolinyl and benzothiazolyl modulators
|
|
NZ526581A
(en)
|
2000-12-26 |
2004-12-24 |
Res Dev Foundation |
Acetyl-coenzyme A carboxylase 2 as a target in the regulation of fat burning, fat accumulation, energy homeostasis and insulin action
|
|
PL367077A1
(en)
|
2001-06-07 |
2005-02-21 |
Eli Lilly And Company |
Modulators of peroxisome proliferator activated receptors (ppar)
|
|
US6987123B2
(en)
|
2001-07-26 |
2006-01-17 |
Cadila Healthcare Limited |
Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
|
|
MXPA04001399A
(es)
*
|
2001-08-13 |
2004-05-27 |
Janssen Pharmaceutica Nv |
Derivados de tiazolilo 2-amino-4,5-trisustituidos.
|
|
JPWO2003026661A1
(ja)
*
|
2001-09-14 |
2005-01-06 |
山之内製薬株式会社 |
インスリン分泌促進剤及び新規なピリミジン誘導体
|
|
JP2005162612A
(ja)
*
|
2002-01-09 |
2005-06-23 |
Ajinomoto Co Inc |
アシルスルホンアミド誘導体
|
|
ATE369855T1
(de)
|
2002-02-25 |
2007-09-15 |
Lilly Co Eli |
Modulatoren von peroxisome proliferator- aktivierten rezeptoren
|
|
EP1478437B1
(en)
|
2002-02-27 |
2005-08-31 |
Pfizer Products Inc. |
Acc inhibitors
|
|
EP1572629A1
(en)
*
|
2002-12-12 |
2005-09-14 |
Galderma Research & Development, S.N.C. |
COMPOUNDS WHICH MODULATE PPARϝ TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
|
|
WO2004089918A1
(ja)
*
|
2003-04-09 |
2004-10-21 |
Japan Tobacco Inc. |
複素芳香５員環化合物及びその医薬用途
|
|
JP2005272476A
(ja)
*
|
2003-04-09 |
2005-10-06 |
Japan Tobacco Inc |
複素芳香５員環化合物及びその医薬用途
|
|
JP2007501267A
(ja)
|
2003-05-27 |
2007-01-25 |
ソシエテ ド コンセイユ ド ルシェルシェ エ ダアップリカーション シャンティフィック（エス．セー．エール．アー．エス．） |
新規イミダゾール誘導体、その製造法及びその医薬としての使用
|
|
JP4638423B2
(ja)
|
2003-06-20 |
2011-02-23 |
ガルデルマ・リサーチ・アンド・デヴェロップメント |
ＰＰＡＲγタイプ受容体を調節する新規化合物および化粧品組成物または医薬品組成物へのその使用
|
|
GB2404855A
(en)
|
2003-07-07 |
2005-02-16 |
Pantherix Ltd |
Arylcarboxylic acid derivatives and their therapeutic use
|
|
AR045047A1
(es)
|
2003-07-11 |
2005-10-12 |
Arena Pharm Inc |
Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
|
|
EP1648875A1
(en)
*
|
2003-07-30 |
2006-04-26 |
Cyclacel Limited |
2-aminophenyl-4-phenylpyrimidines as kinase inhibitors
|
|
CN1845915A
(zh)
*
|
2003-09-02 |
2006-10-11 |
默克公司 |
作为亲代谢谷氨酸受体－5的调节剂的联吡啶胺和醚类化合物
|
|
US7714009B2
(en)
|
2003-10-31 |
2010-05-11 |
Takeda Pharmaceutical Company Limited |
Nitrogen-containing fused heterocyclic compounds
|
|
EP1687299A1
(en)
|
2003-11-20 |
2006-08-09 |
Eli Lilly And Company |
Heterocyclic compounds as modulators of peroxisome proliferator activated receptors, useful for the treamtment and/or prevention of disorders modulated by a ppar
|
|
WO2005058876A1
(en)
*
|
2003-12-16 |
2005-06-30 |
Gpc Biotech Ag |
Pyrazine derivatives as effective compounds against infectious diseases
|
|
AU2004309271A1
(en)
*
|
2003-12-25 |
2005-07-14 |
Takeda Pharmaceutical Company Limited |
3-(4-benzyloxyphenyl)propanoic acid derivatives
|
|
US7470712B2
(en)
|
2004-01-21 |
2008-12-30 |
Bristol-Myers Squibb Company |
Amino-benzazoles as P2Y1 receptor inhibitors
|
|
US20050267221A1
(en)
|
2004-05-14 |
2005-12-01 |
Research Development Foundation |
Use of curcumin and analogues thereof as inhibitors of ACC2
|
|
NZ552187A
(en)
|
2004-06-18 |
2010-08-27 |
Millennium Pharm Inc |
Thiophene-2-carboxamide derivatives
|
|
US20050288340A1
(en)
|
2004-06-29 |
2005-12-29 |
Pfizer Inc |
Substituted heteroaryl- and phenylsulfamoyl compounds
|
|
JP2006022065A
(ja)
|
2004-07-09 |
2006-01-26 |
Dai Ichi Seiyaku Co Ltd |
カルバメート誘導体
|
|
WO2006011631A2
(en)
*
|
2004-07-27 |
2006-02-02 |
Astellas Pharma Inc. |
Thiazole derivatives having vap-1 inhibitory activity
|
|
US20090196912A1
(en)
*
|
2004-07-30 |
2009-08-06 |
Gpc Botech Ag |
Pyridinylamines
|
|
US7645778B2
(en)
*
|
2005-01-19 |
2010-01-12 |
Bristol-Myers Squibb Company |
Heteroaryl compounds as P2Y1 receptor inhibitors
|
|
US8748627B2
(en)
|
2006-02-15 |
2014-06-10 |
Abbvie Inc. |
Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome
|
|
EP1996567B1
(en)
|
2006-02-15 |
2013-09-18 |
AbbVie Inc. |
Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
|
|
WO2008079610A2
(en)
|
2006-12-21 |
2008-07-03 |
Abbott Laboratories |
Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
|
|
KR20100031528A
(ko)
|
2007-06-01 |
2010-03-22 |
더 트러스티즈 오브 프린스턴 유니버시티 |
숙주세포 대사경로의 조절을 통한 바이러스 감염 치료
|